Laboratorios Sanfer Acquires Vitalis from ACON Investments

January 18, 2024

Laboratorios Sanfer has acquired Vitalis S.A.C.I., a Bogotá-based manufacturer and wholesaler of injectable pharmaceuticals, from ACON Investments. The transaction — first announced under a definitive agreement in January 2024 and completed in February 2025 — expands Sanfer's manufacturing footprint and product portfolio across Latin America; terms were not disclosed.

Buyers
Laboratorios Sanfer, S.A. de C.V.
Targets
Vitalis S.A.C.I.
Sellers
ACON Investments
Industry
Pharmaceuticals
Location
Bogotá, Colombia
Transaction Type
Divestiture

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.